סילוונט 100 מג Israel - Tiếng Do Thái - Ministry of Health

סילוונט 100 מג

medison pharma ltd - siltuximab - אבקה להכנת תמיסה מרוכזת לעירוי - siltuximab 100 mg - siltuximab

סילוונט 400 מג Israel - Tiếng Do Thái - Ministry of Health

סילוונט 400 מג

medison pharma ltd - siltuximab - אבקה להכנת תמיסה מרוכזת לעירוי - siltuximab 400 mg

מגלוטקט Israel - Tiếng Do Thái - Ministry of Health

מגלוטקט

kamada ltd - cytomegalovirus antibody 50 iu/ml; human plasma protein 100 mg/ml - solution for injection - cytomegalovirus immunoglobulin - prophylaxis of clinical manifestations of cytomegalovirus infection in patients subjected to immunosuppressive therapy, particularly in transplant recipients.

נרלינקס Israel - Tiếng Do Thái - Ministry of Health

נרלינקס

medison pharma ltd - neratinib as maleate - טבליה - neratinib as maleate 40 mg - neratinib

מנוגון Israel - Tiếng Do Thái - Ministry of Health

מנוגון

ferring pharmaceuticals ltd - follicle stimulating hormone (fsh); luteinizing hormone - אבקה וממס להכנת תמיסה להזרקה - follicle stimulating hormone (fsh) 75 iu/vial; luteinizing hormone 75 iu/vial - gonadotropins - sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism.

ברינרט Israel - Tiếng Do Thái - Ministry of Health

ברינרט

csl behring ltd., israel - c - 1 esterase inhibitor human - אבקה להמסה להזרקה\אינפוזיה - c - 1 esterase inhibitor human 500 iu/vial - c1- inhibitor,plasma derived - c1- inhibitor,plasma derived - hereditary angioedema type i and ii (hea) , treatment of acute episodes.

בריגלובין פי. Israel - Tiếng Do Thái - Ministry of Health

בריגלובין פי.

csl behring ltd., israel - immunoglobulins, normal human - תמיסה להזרקה - immunoglobulins, normal human 160 mg/ml - immunoglobulins, normal human, for extravascular adm. - immunoglobulins, normal human, for extravascular adm. - substitution in - primary antibody deficiency syndromes resulting from defective antibody synthesis. - protracted transitory hypogammaglobulinaemia especially in premature infants .prophylaxis of hepatitis a- before exposure- within 2 weeks after exposure

פלבוגאמה % 5 דיפ Israel - Tiếng Do Thái - Ministry of Health

פלבוגאמה % 5 דיפ

medici medical ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 0.5 g / 10 ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: primary immunodeficiency syndromes such as:- congenital agammaglobulinaemia and hypogammaglobulinaemia- common variable immunodeficiency- severe combined immunodeficiency- wiskott aldrich syndromemyeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.children with congenital aids and recurrent infections.immunomodulation :idiopathic thrombocytopenic purpura (itp), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count.guillain barr? syndrome.kawasaki disease.allogeneic bone marrow transplantation

אומר-יג-אם % 5 Israel - Tiếng Do Thái - Ministry of Health

אומר-יג-אם % 5

omrix biopharmaceuticals - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 50 mg/ml mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy * primary immunodeficiency (patients with primary defective antibody synthesis such as agammaglobulinemia or hypogammaglobulinemia) * myeloma or chronic lymphocytic leukemia (cll) with severe secondary hypogammaglobulinemia and recurrent infections. * children with congenital aids and recurrent infections - immunomodulation * idiopathic thrombocytopenic purpura (itp) * guillain barre syndrome * kawasaki disease - allogenic bone marrow transplantation

אוקטאגם Israel - Tiếng Do Thái - Ministry of Health

אוקטאגם

dover medical & scientific equipment ltd, israel - immunoglobulins, normal human - תמיסה לאינפוזיה - immunoglobulins, normal human 50 mg/ml - immunoglobulins, normal human, for intravascular adm. - immunoglobulins, normal human, for intravascular adm. - replacement therapy in: • primary immunodeficiency syndromes such as: - congenital agammaglobulinaemia and hypogammaglobulinaemia - common variable immunodeficiency - severe combined immunodeficiency - wiskott aldrich syndrome. • children with congenital aids and recurrent bacterial infections. immunomodulatory effect: • idiopathic thrombocytopenic purpura (itp) in children or adults at high risk of bleeding or prior to surgery to correct the platelet count. • guillain barre syndrome. • kawasaki disease. allogeneic bone marrow transplantation.• myeloma or chronic lymphatic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections.